IQVIA number of employees

IQVIA reported 93,000 employees at December 31, 2025 in its latest annual report, up 5,000 (5.7%) on the year before. That compares with 79,000 at December 31, 2021. Revenue per employee was $175,376.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2025	93,000	+5,000 (5.7%)	$175,376	10-K, filed February 17, 2026
December 31, 2024	88,000	+1,000 (1.1%)	$175,057	10-K, filed February 13, 2025
December 31, 2023	87,000	+1,000 (1.2%)	$172,230	10-K, filed February 15, 2024
December 31, 2022	86,000	+7,000 (8.9%)	$167,558	10-K, filed February 15, 2023
December 31, 2021	79,000	—	$175,620	10-K, filed February 16, 2022

What the annual reports say

Our approximately 93,000 employees drive our vision to power smarter healthcare for everyone, everywhere. 2025 annual report
Our approximately 88,000 employees drive our vision to power smarter healthcare for everyone, everywhere. 2024 annual report
Our approximately 87,000 employees help us drive our business success and achieve our ambition to advance human health. 2023 annual report
Our approximately 86,000 employees help us drive our business success and achieve our ambition to advance human health. 2022 annual report
Our approximately 79,000 employees help us drive our business success and achieve our ambition to advance human health. 2021 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: DHR vs IQV A vs IQV IQV vs TMO

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from IQVIA's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to IQVIA.